Skip to main content
. 2016 Oct 12;7(46):76006–76020. doi: 10.18632/oncotarget.12579

Figure 4. IL-23 is required for stable expression of stem cell markers in CD133+ CSLCs.

Figure 4

A. Representative western blot analysis of Nanog, Oct4 and Sox2 expression in Control shRNA (vector) or IL-23p19-shRNA transfected CD133+ A2780 cells. B. Immunofluorescence detection of Nanog, Oct4 and Sox2 expression in Control shRNA (vector) or IL-23p19-shRNA transfected CD133+ A2780 spheres. Scale bars, 25μm.